Pesquisas alternativas:
does develop » boys develop (Expandir a Pesquisa), loss develop (Expandir a Pesquisa), does developing (Expandir a Pesquisa)
develop them » develop type (Expandir a Pesquisa)
doses levels » dose level (Expandir a Pesquisa), assess levels (Expandir a Pesquisa), dosage levels (Expandir a Pesquisa)
levels other » levels another (Expandir a Pesquisa), levels rather (Expandir a Pesquisa), levels over (Expandir a Pesquisa)
dose levels » noise levels (Expandir a Pesquisa)
drug doses » drug disease (Expandir a Pesquisa)
drug does » drugs does (Expandir a Pesquisa), drug de (Expandir a Pesquisa), drug diet (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
does develop » boys develop (Expandir a Pesquisa), loss develop (Expandir a Pesquisa), does developing (Expandir a Pesquisa)
develop them » develop type (Expandir a Pesquisa)
doses levels » dose level (Expandir a Pesquisa), assess levels (Expandir a Pesquisa), dosage levels (Expandir a Pesquisa)
levels other » levels another (Expandir a Pesquisa), levels rather (Expandir a Pesquisa), levels over (Expandir a Pesquisa)
dose levels » noise levels (Expandir a Pesquisa)
drug doses » drug disease (Expandir a Pesquisa)
drug does » drugs does (Expandir a Pesquisa), drug de (Expandir a Pesquisa), drug diet (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
1
“... products (e.g., drugs) but preclude them from others (e.g., food additives). When not precluded...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
“... data on safety, dosing, and the choice of anti-VEGF drug are still lacking. CONCLUSION: The available...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Abhilash, B., Tripathi, Chakra Dhar, Gogia, Anoop Raj, Meshram, Girish Gulab, Kumar, Manu, Suraj, B.
Publicado no Indian J Crit Care Med (2015)
“... and the nongastrointestinal groups was significant at 2 h (P = 0.015) following drug dosing; while the difference...”Publicado no Indian J Crit Care Med (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por King, Shelby M., Higgins, J. William, Nino, Celina R., Smith, Timothy R., Paffenroth, Elizabeth H., Fairbairn, Casey E., Docuyanan, Abigail, Shah, Vishal D., Chen, Alice E., Presnell, Sharon C., Nguyen, Deborah G.
Publicado no Front Physiol (2017)
“... site of nephrotoxicity and resulting attrition in the drug development pipeline. Current pre-clinical...”Publicado no Front Physiol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Karolina Jolanta Banyś, Monika Wioletta Knopczyk, Barbara Bobrowska-Korczak
Publicado em 2020-03-01
“... took vitamin B12. In addition, in one of them women supplemented with L-5-MTHFR, and in the other...”Publicado em 2020-03-01
Obter o texto integral
Artigo
6
Publicado em 2009
“..., with the attendant limitations of their nonphysiological transcriptional regulation and levels of expression...”Obter o texto integral
Obter o texto integral
Artigo
7
Publicado no Mol Cell Proteomics
(2017)
“... drug development studies. Novel Aspect: Quantitation of rabbit and cynomolgus monkey species-matched...”Obter o texto integral
Artigo
8
Publicado no Mol Cell Proteomics
(2017)
“... clinical efficacy and dose-limiting toxicities in patients treated with these drugs. More broadly, we...”Obter o texto integral
Artigo